Moreover, in the study by Zhang et al., combination antibody treatment with anti-PD-1 and anti-CTLA-4 resulted in myocarditis development, associated with decreased levels of 17-β-estradiol in female mice treated with ICIs [125]. The gene discussed is CTLA4; the disease is myocarditis.